According to recent data, nonalcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25% and is the top cause of chronic liver problems among the world’s populations. One of the most significant risks for NAFLD is obesity, which also has associations with higher levels of systemic inflammation. This, in turn, can make the symptoms of NAFLD even worse. Because liver conditions and obesity are so widespread, researchers are always on the lookout for new, effective ways of preventing and treating them when they do occur. Recently, a team of specialists from Texas A&M University — in collaboration with colleagues from other research institutions — have conducted a study that suggests that a particular natural compound, called indole, could improve NAFLD.
